Preliminary schedule
1. Afternoon Scientific session 13:30-18:00
13:30 Opening registration
14:00 Welcome and opening of the symposium
14:10 Highly pathogenic avian influenza H5 virus as a continuing pandemic threat
Prof. Ron Foucher - Erasmus MC department of Viroscience
14:40 Organisation of NRC: Battery of tests available at NRC and unresolved maxipanels
Prof. dr. Emmanuel André - Laboratoriumgeneeskunde, UZ Leuven
15:00 SARI Surveillance
Sr. Yinthe Dockx - Sciensano
15:20 Alternative/complementary surveillance
To be communicated - Sciensano
15:40 Coffee break
16:10 Mycoplasma pneumoniae and other respiratory bacteria
Prof. dr. Pharm. biol. Veerle Matheeussen - UZA
16:35 Position of the virus bank: viral typing, phenotyping, whole genome sequencing
Prof. Peter Delputte - ReViRAnt, UAntwerpen
17:00 Pandemic preparedness: The importance of Controlled Human Infection (CHIM) studies for evaluating respiratory viral vaccines and therapeutics
Sr. Bart Van Meerbergen - Vaccinopolis
17:25 Models and tools for research on respiratory viral infections
dr. Koert Stittelaar - KULeuven
2. Registration evening session and walking dinner 18:00-19:00
3. Evening policy and clinical session 19:00-20:55
19:00 Opening evening session
19:10 Policy talk
To be communicated
19:25 Wrap up of winter season
MD Yves Lafort - Sciensano
19:40 The AS01E-adjuvanted RSVPreF3 vaccine exhibits broad efficacy against diverse RSV strains
dr. Lucile Warter - GSK
19:55 Efficacy, Effectiveness and Clinical Development Programme of RSVpreF
MD Machteld De Bock and dr. Keliane Liberman - Pfizer
20:10 Sanofi as partner in RSV prevention
MD Patrick Dhont - Sanofi
20:25 To be communicated
dr. Chloé Abels - MSD
20:40 Lessons learned from the RAG
To be communicated
4. End of symposium and reception - 20:55 - 21:55
Note: This is a preliminary schedule. The final schedule, including allocated Q&A time, will be adjusted based on speaker confirmations and may include extended Q&A sessions. Any changes will be communicated promptly.